Nikolas Plevris - Concepedia

Author

Nikolas Plevris

Western General Hospital ORCID

Also Known As

Marie Vibeke Vestergaard, N PLEVRIS, N Plevris, N. Plevris, Nik Plevris, Nikolaos Plevris, Nikolas Plevris, Plevris N

131

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Western General Hospital University of Edinburgh Institute of Genetics and Cancer Centre for Inflammation Research The Queen's Medical Research Institute

About

Nikolas Plevris is an author at Western General Hospital specializing in medicine, gastroenterology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	73
2	Gastroenterology	2	2	73
3	Pathology	1	1	41
4	Gastrointestinal Pathology	1	1	41
5	Disease Progression	1	1	41

Nikolas Plevris

Publications

999

Citations

H-Index

Page 1

	Year	Citations
IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Gut	2019	201
Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease Nicholas A. Kennedy, Gareth‐Rhys Jones, Nikolas Plevris, Clinical Gastroenterology and Hepatology	2019	87
Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn’s disease Nikolas Plevris, Philip Jenkinson, Ian Arnott, European Journal of Gastroenterology & Hepatology	2019	79
Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy Uri Kopylov, Jurij Hanžel, Claire Liefferinckx, Alimentary Pharmacology & Therapeutics	2020	78
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis Rebecca K Grant, Gareth‐Rhys Jones, Nikolas Plevris, Inflammatory Bowel Diseases	2020	63
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort Nikolas Plevris, Cher Shiong Chuah, Rhiannon Allen, Journal of Crohn s and Colitis	2019	50
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study Nathaniel A. Cohen, Nikolas Plevris, Uri Kopylov, United European Gastroenterology Journal	2020	49
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease Nikolas Plevris, James Fulforth, Mathew Lyons, Clinical Gastroenterology and Hepatology Reduced RiskFecal CalprotectinUrologyDisease ProgressionGastroenterology	2020	41
Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort Nikolas Plevris, James Fulforth, Spyros I. Siakavellas, Journal of Gastroenterology and Hepatology	2020	39
Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn’s Disease: A Population-based Cohort Study Philip Jenkinson, Nikolas Plevris, Spyros I. Siakavellas, Journal of Crohn s and Colitis	2020	35

Page 1